Medisolv

Medisolv Competitive Intelligence & Landscape

medisolv.com ·

Medisolv
ForesightIQ Predictions

What is Medisolv likely to do next?

ForesightIQ connects Medisolv's hiring, product, web, ad, and market signals to forecast strategic moves — often months before they're announced.

Hiring signal

Senior hiring patterns point to a planned enterprise product line launching within two quarters.

High confidence · Next 1–2 quarters
Product signal

Quiet changes to docs and pricing pages signal an upcoming usage-based pricing tier and new API surface.

Likely · Next quarter
Market signal

Ad spend and partnership activity indicate a push into the mid-market segment across two new regions.

Plausible · Next 2–3 quarters
Medisolv Unlock Medisolv's predicted moves

Free · generated in ~60 seconds · no signup to preview

Overview

Medisolv Overview

Medisolv, Inc. (medisolv.com) is a leading healthcare technology company dedicated to advancing the quality of care within healthcare systems through sophisticated data measurement and analytics solutions. Founded in 1999 with the belief that technology combined with human ingenuity can lead to better healthcare outcomes, Medisolv provides comprehensive software and services designed to help healthcare providers effectively monitor, manage, and improve their quality performance [medisolv.com/about-medisolv]. The company's headquarters are located in Columbia, MD [medisolv.com/contact-us].

Medisolv offers a suite of Quality Solutions that includes packages for Hospital Quality Reporting, MVP Reporting, MIPS Reporting, and ACO APP Reporting. Beyond compliance-focused tools, their offerings extend to performance improvement solutions like QualityIQ for system-wide performance insights, Advisory Services for quality improvement consulting, and the Hospital Star Rating Analyzer for actionable CMS Star Ratings insights. They also provide Advanced Quality Improvement (AQI), a subscription-based service for year-round support and optimization [medisolv.com]. In 2023, Medisolv received a strategic investment from BVP Forge to accelerate its growth, underscoring its position as a key player in healthcare quality data solutions [blog.medisolv.com/articles/medisolv-receives-strategic-investment-from-bvp-forge].

The company's mission revolves around creating solutions that enable everyday improvements for America's healthcare providers and their patients [medisolv.com/about-medisolv].

Medisolv is approved as a CMS Qualified Clinical Data Registry for 2026, showcasing its commitment to regulatory excellence and comprehensive data management [blog.medisolv.com/articles/medisolv-approved-as-a-cms-qualified-clinical-data-registry-for-2026]. In a strategic move to enhance its capabilities, Medisolv acquired Health Elements AI, integrating technology to capture and structure clinical data from medical records, further reducing administrative burden and broadening its analytics offerings [blog.medisolv.com/articles/medisolv-acquires-health-elements-ai]. David Lucey Jr. assumed the role of CEO in September 2024, succeeding founder Dr. Zahid Butt, bringing over 30 years of executive leadership experience in healthcare technology [medisolv.com/leadership][blog.medisolv.com/articles/medisolv-welcomes-david-lucey-jr.-as-chief-executive-officer].

Competitors

Medisolv Competitors

Medisolv, a Maryland-based SaaS platform founded in 1999, specializes in healthcare quality data measurement and reporting for hospitals and ambulatory care providers [https://www.owler.com/company/medisolv]. Their core offering is a quality management software platform, ENCOR, designed to help healthcare organizations measure and improve performance on critical quality and safety metrics [https://healthcare.toolsinfo.com/tool/medisolv].

Medisolv provides solutions for Hospital Quality Reporting, MVP Reporting, MIPS Reporting, and ACO APP Reporting, alongside performance tools like QualityIQ and Advisory Services [https://medisolv.com]. While Electronic Health Records (EHRs) can handle basic reporting, Medisolv emphasizes that its purpose-built solutions offer a higher level of efficiency and accuracy, complementing rather than competing directly with EHR vendors in the eCQM space [https://medisolv.com/medisolv-vs-ehrs, https://blog.medisolv.com/articles/better-together-how-ehrs-and-medisolv-strengthen-quality-reporting].

Among Medisolv's direct competitors is CloudMedx, a healthcare technology company that integrates artificial intelligence into its data platforms [https://www.cbinsights.com/company/medisolv].

CloudMedx differentiates itself by offering tools for workflow automation, population health management, cost analytics, and patient engagement, aiming to enhance decision-making and efficiency within healthcare organizations [https://www.cbinsights.com/company/medisolv]. While Medisolv focuses on comprehensive quality reporting and improvement, CloudMedx emphasizes AI-driven insights and a broader suite of tools for operational and financial optimization. Both companies serve the healthcare sector, but CloudMedx's AI integration might appeal to organizations prioritizing advanced analytics and automation beyond core quality reporting.

Change Healthcare is another significant competitor, offering a wide array of healthcare technology solutions [https://leadiq.com/c/medisolv-inc/5a1d82b124000024005d4ea8]. While Medisolv is highly specialized in quality management, Change Healthcare provides a more extensive portfolio that spans revenue cycle management, payment solutions, and clinical decision support. This broader market positioning means Change Healthcare often serves as a comprehensive vendor for various healthcare IT needs, potentially encompassing some quality reporting functionalities as part of a larger ecosystem. Compared to Medisolv's focused approach, Change Healthcare's offerings are more integrated and diverse, catering to organizations looking for a single vendor for multiple IT requirements.

Strata Decision Technology also competes in the healthcare technology space, with a particular focus on financial planning and performance management for healthcare providers [https://leadiq.io/c/medisolv-inc/5a1d82b124000024005d4ea8]. Their solutions often involve budgeting, forecasting, and cost accounting to help healthcare organizations improve financial performance. While Medisolv aids in clinical quality improvement that can indirectly impact finances, Strata Decision Technology directly addresses the financial health of hospitals and health systems. This makes Strata Decision Technology a strong competitor for organizations prioritizing financial efficiency and resource allocation, contrasting with Medisolv's primary emphasis on clinical quality metrics and regulatory compliance.

Finally, MiCare Path is identified as a competitor to Medisolv [https://www.cbinsights.com/company/medisolv]. Although specific details about MiCare Path's offerings are not extensively available in the provided sources, its positioning as a competitor suggests it likely provides solutions within the realm of healthcare data management, patient engagement, or quality reporting. Given Medisolv's focus on quality management software for hospitals and physicians, MiCare Path likely offers a similar or complementary service, potentially with different features, pricing models, or a niche market focus. A detailed comparison would require more information on MiCare Path's specific functionalities and target audience.

Alternatives

Medisolv Alternatives

Product & Pricing

Medisolv Product and Pricing Intelligence

Medisolv (medisolv.com) offers a comprehensive suite of quality reporting and improvement solutions tailored for hospitals and clinicians, focusing on compliance and enhanced patient outcomes. While specific pricing plans and tiers are not publicly disclosed, Medisolv provides various packages and subscription-based services. Their core offerings include the MIPS Value Pathways (MVP) Reporting Package which is fully certified to meet CMS requirements and supports all active MVPs in 2025, including new and voluntary measures [medisolv.com/mvp-reporting-package]. They also feature Hospital Quality Reporting, MIPS Reporting, and ACO APP Reporting as compliance-focused packages.

Key products like ENCOR for Electronic Hospital Measures provide daily refreshed eCQM data for near real-time insights and access to all active eCQMs [medisolv.com/encor-for-hospital-electronic-measures]. Similarly, ENCOR for Clinician Registry Measures, also known as Medisolv QCDR, automates data loading from EHRs daily, pre-populating cases and sorting them by status for efficient abstraction [medisolv.com/encor-for-clinician-registry-measures]. The RAPID Clinical & Business Intelligence tool offers lightning-fast data, powerful EHR integration, and daily updates for timely interventions, allowing tracking of readmissions and forecasting [medisolv.com/rapid-clinical-business-intelligence].

Beyond reporting, Medisolv provides advanced tools and services for performance improvement. The Hospital Star Rating Analyzer Module helps facilities understand how their data impacts star scores and prioritize quality improvement efforts [medisolv.com/hospital-star-rating]. The Value Maximizer is a predictive modeling engine that forecasts performance and payments up to two years in advance, helping manage CMS hospital quality programs (HVBP, HAC, HRRP) and identify potential penalties [medisolv.com/value-maximizer]. For ongoing support, Advanced Quality Improvement (AQI) is a subscription-based service offering strategic quality improvement, expert advisory support, and customized services to drive measurable results beyond mere compliance [medisolv.com/advisory-services/advanced-quality-improvement]. Additionally, the Medisolv Quality Academy provides exclusive access to expert guidance, tools, and real-time answers for CMS reporting for Medisolv customers [medisolv.com/quality-academy], complementing their Quality365® Approach for continuous improvement [medisolv.com/medisolv-quality365].

Hiring & Layoffs

Medisolv Hiring and Layoffs

Medisolv (medisolv.com), a company dedicated to advancing healthcare quality through technology since 1999, demonstrates a consistent strategy of investing in its workforce to support its mission. The company frequently highlights its commitment to a strong company culture, emphasizing diversity and a healthy work-life balance as key components of joining their team [medisolv.com/careers]. This approach suggests a focus on sustainable growth and attracting talent aligned with their core values.

While specific recent hiring numbers or explicit layoff announcements are not readily available on their public-facing pages, Medisolv consistently invites individuals to explore their "Open Positions" on their careers page [medisolv.com/careers]. Their leadership team reiterates the company's continuous effort to add more team members, indicating ongoing recruitment efforts [medisolv.com/leadership]. This pattern aligns with a company that is actively expanding its capabilities to meet the evolving demands of healthcare quality improvement.

Medisolv's strategic focus is further evidenced by its significant reinvestment of 47% of its revenue back into research and innovation [medisolv.com/research-innovation]. This commitment to continuous development suggests a need for skilled professionals in areas such as technology, data analytics, and healthcare quality advising. Their emphasis on dedicated quality advisors and customer experience teams also points to a demand for client-facing and support roles to ensure effective implementation and utilization of their quality solutions [medisolv.com/mission, medisolv.com/customer-experience]. The continuous recruitment implied by their careers page and leadership statements signals a company that is proactively strengthening its team to maintain its position as an industry leader in healthcare quality technology.

Leadership

Medisolv Management and Leadership Team

Medisolv, a leader in healthcare quality data management, experienced a significant leadership transition with David Lucey Jr. stepping into the role of Chief Executive Officer on September 24, 2024. Lucey brings over 30 years of executive leadership experience in healthcare technology solutions and Software as a Service (SaaS), with a proven track record of driving growth and profitability. He previously served as CEO at Biscom, where he oversaw its acquisition by Concord Technologies [blog.medisolv.com/articles/medisolv-welcomes-david-lucey-jr.-as-chief-executive-officer].

Following this transition, Medisolv founder and former CEO Dr. Zahid Butt moved to the Board of Directors, continuing to serve as a strategic advisor [blog.medisolv.com/articles/medisolv-welcomes-david-lucey-jr.-as-chief-executive-officer]. Dr. Butt has been a prominent figure in healthcare quality, recognized with the HIMSS 2023 Changemaker in Health Policy Influencer Category Award and appointed to the Partnership for Quality Measurement’s 2024-2025 Pre-Rulemaking Measure Review Hospital Committee [blog.medisolv.com/articles/medisolv-ceo-dr.-zahid-butt-appointed-to-partnership-for-quality-measurements-2024-2025-pre-rulemaking-measure-review-hospital-committee].

The executive leadership team at Medisolv also includes other key individuals. Bryan Hoke was appointed as Chief Growth Officer on January 20, 2022, responsible for the company's overall go-to-market strategy and business development [blog.medisolv.com/articles/medisolv-appoints-bryan-hoke-chief-growth-officer]. Scott Allen, Medisolv's Chief Technology Officer, was honored as a Microsoft Regional Director in August 2019, acknowledging his status as a top technology visionary [blog.medisolv.com/articles/microsoft-appoints-medisolv-cto-regional-director]. Erin Heilman, CPHQ, serves as Senior Vice President of Regulatory Affairs & Advisory Services, bringing her expertise in healthcare quality regulatory space to the team [medisolv.com/advisory-services].

Financials

Medisolv Financial Performance, Fundraising, M&A

While specific revenue figures for Medisolv are not publicly disclosed, the company has secured a significant strategic investment to fuel its growth. In May 2023, BVP Forge completed a strategic investment in Medisolv Inc. to accelerate its expansion [blog.medisolv.com/articles/medisolv-receives-strategic-investment-from-bvp-forge]. This investment underscores confidence in Medisolv's position as a leader in healthcare quality data measurement and reporting solutions.

Medisolv was founded in 1999, emphasizing the belief that software could extract intelligence from healthcare data to enhance both quality of care and financial outcomes [blog.medisolv.com/articles/medisolv-receives-strategic-investment-from-bvp-forge]. The company's longevity and recent strategic investment indicate a stable financial foundation and a strong growth trajectory within the competitive healthcare technology sector. The company's offerings, including Hospital Quality Reporting, MIPS Reporting, MVP Reporting, and ACO APP Reporting, contribute to its sustained market presence and financial health [medisolv.com].

Under the leadership of its CEO, who brings over 30 years of executive experience in healthcare technology and Software as a Service (SaaS), Medisolv has demonstrated a commitment to innovative solutions and substantial growth [medisolv.com/leadership]. This leadership has guided Medisolv through strategic partnerships, such as joining the MEDITECH Alliance program in July 2025 to advance total quality improvement for hospitals [blog.medisolv.com/articles/medisolv-and-meditech-partner-to-advance-total-quality-improvement-for-hospitals]. These collaborations and its consistent approval as a CMS Qualified Clinical Data Registry further solidify its market position and potential for continued financial performance [blog.medisolv.com/articles/medisolv-approved-as-a-cms-qualified-clinical-data-registry-for-2026].

Partnerships

Medisolv Partnerships, Clients and Vendors

Medisolv actively cultivates strategic partnerships and client relationships to enhance its quality management and reporting solutions within the healthcare ecosystem. A notable collaboration includes joining the MEDITECH Alliance program in July 2025, which aims to help hospitals transform clinical data into performance insights [blog.medisolv.com/articles/medisolv-and-meditech-partner-to-advance-total-quality-improvement-for-hospitals]. Furthermore, Medisolv partnered with Trinexus, a healthcare IT consulting firm, in October 2022 to improve quality management across Puerto Rico and Caribbean markets [blog.medisolv.com/articles/trinexus-medisolv-partnership]. The company also works with CloudWave to offer its quality management and reporting Software as a Service (SaaS) model, enabling hospitals hosted on CloudWave to leverage Medisolv's solutions [blog.medisolv.com/articles/medisolv-cloudwave-announce-cloud-based-quality-reporting-solutions-healthcare].

Medisolv has established significant agreements with large healthcare organizations, notably with Vizient, Inc. Since April 2018, Medisolv has been providing Vizient member hospitals and affiliated physicians with its ENCOR quality management software and submission services for electronic quality measurement and reporting [blog.medisolv.com/articles/medisolv-agreement-offers-vizient-members-advanced-solutions-quality-reporting]. This relationship expanded in April 2019 to include the ENCOR Quality Management Platform for chart-abstracted core measures, building on the existing eCQM management solution [blog.medisolv.com/articles/vizient-agreement-medisolv-enhanced-solution-core-measures-abstraction-regulatory-reporting]. These partnerships underscore Medisolv's commitment to simplifying regulatory compliance and improving efficiency for its diverse client base.

In terms of public sector collaboration, Medisolv has been instrumental in Maryland's digital quality reporting initiative. In June 2022, the State of Maryland partnered with CRISP, Maryland’s state-designated health information exchange, and Medisolv to become the first state in the U.S. to accept electronic clinical quality measure (eCQM) data from hospitals [blog.medisolv.com/articles/maryland-collaboration-crisp-medisolv-accept-ecqms]. This leadership role continued in March 2025, with Medisolv at the forefront of enhancing transparency and patient care through this pioneering initiative [blog.medisolv.com/articles/medisolv-leads-maryland-digital-quality-reporting].

Medisolv's specialized focus on quality reporting has earned the trust of providers and even major names in healthcare IT, with EHR vendors referring providers directly for eCQM support, highlighting its expertise where EHRs alone may not suffice [blog.medisolv.com/articles/better-together-how-ehrs-and-medisolv-strengthen-quality-reporting].

Events

Medisolv Event Participations

Medisolv (medisolv.com) actively participates in, sponsors, and hosts various events, including major industry conferences, its own annual virtual conference, and a robust schedule of educational webinars. The company consistently engages with the healthcare quality community, offering opportunities for learning, networking, and staying current with regulatory changes. These events are crucial for Medisolv to share its expertise and connect with healthcare professionals seeking to enhance quality improvement.

Medisolv is a prominent participant in key industry conferences. For instance, they will be at the MUSE Inspire Conference from May 19-22, 2026, where their experts will discuss the CMS’s new Ambulatory Specialty Model (ASM) and its organizational implications.

Medisolv also demonstrates its commitment to the quality community by sponsoring events like the MAHQ Annual Conference on May 28, 2026, providing direct engagement opportunities with their team [medisolv.com/events]. These participations highlight Medisolv's role in shaping and contributing to discussions around healthcare quality and compliance.

Annually, Medisolv hosts its own signature virtual event, the Medisolv HERE Conference. This conference, designed for healthcare quality leaders, focuses on turning healthcare changes into advantages through sessions on data, strategy, and patient safety, all under the theme “Quality Solves Everything” [blog.medisolv.com/articles/here25-recap]. The HERE25 Conference, held on September 24-25, 2025, gathered over 1,200 attendees to explore how modern quality programs drive measurable outcomes [go.medisolv.com/medisolv-here-conference-2025]. This event is a central platform for Medisolv to disseminate crucial information and foster a community of quality improvement.

Beyond conferences, Medisolv maintains a comprehensive Education Center that features numerous webinars, both upcoming and on-demand [medisolv.com/education-center]. These webinars cover critical topics such as the 2026 IQR & OQR Requirements, proposed changes to the Quality Payment Program (QPP), the Hybrid Measure Reboot, and mastering CQM and eCQM reporting [medisolv.com/on-demand-webinars]. Examples of on-demand webinars include reviews of the 2025 IPPS Final Rule, 2026 IPPS & IPF PPS Proposed Rules, and discussions on equitable care measures [community.medisolv.com/knowledge/on-demand-review-of-the-2025-ipps-final-rule, go.medisolv.com/webinar-2026-iqr-oqr-requirements]. These educational initiatives underscore Medisolv's dedication to providing continuous learning and resources for healthcare professionals.

Frequently Asked Questions

What does Medisolv's recent acquisition of Health Elements AI signal about its product strategy?

Medisolv's acquisition of Health Elements AI indicates a strategic move to enhance its capabilities in capturing and structuring clinical data from medical records. This integration aims to reduce administrative burdens for providers and expand Medisolv's analytics offerings, suggesting a focus on deeper data insights and operational efficiency beyond traditional quality reporting.

How does Medisolv's partnership with MEDITECH affect its market positioning?

Medisolv's partnership with MEDITECH, joining their Alliance program in July 2025, signals a strategic effort to integrate its quality solutions more deeply within major EHR ecosystems. This collaboration allows Medisolv to help MEDITECH-using hospitals transform clinical data into performance insights, solidifying its role as a complementary, rather than competing, expert in advanced quality measurement.

What does David Lucey Jr.'s appointment as CEO, succeeding founder Dr. Zahid Butt, imply for Medisolv's strategic direction?

David Lucey Jr.'s appointment as CEO in September 2024, bringing over 30 years of executive leadership experience in healthcare technology and SaaS, suggests Medisolv is prioritizing accelerated growth and profitability. This transition, with founder Dr. Zahid Butt moving to the Board, indicates a strategic shift towards leveraging seasoned executive leadership for scaling and market expansion.

What does Medisolv's consistent participation in and hosting of industry events, like the HERE Conference, indicate about its market strategy?

Medisolv's consistent participation in and hosting of events like the annual HERE Conference signifies a strong commitment to thought leadership and community engagement. By sharing expertise on regulatory changes and quality improvement, Medisolv aims to position itself as an indispensable resource and foster a loyal customer base among healthcare quality leaders.

Given the strategic investment from BVP Forge in 2023, what is Medisolv's financial trajectory likely to be?

The strategic investment from BVP Forge in May 2023 indicates a strong growth trajectory for Medisolv. This investment, combined with the company's long-standing presence since 1999 and leadership's focus on innovative solutions, suggests a stable financial foundation and ongoing expansion within the healthcare quality data market.

How does Medisolv's 'Value Maximizer' product differentiate its offerings from basic compliance tools?

Medisolv's 'Value Maximizer' product differentiates its offerings by providing predictive modeling for performance and payments up to two years in advance. This goes beyond basic compliance to help hospitals proactively manage CMS quality programs (HVBP, HAC, HRRP) and identify potential financial penalties, demonstrating a focus on strategic financial and operational optimization.

What does Medisolv's approval as a CMS Qualified Clinical Data Registry for 2026 signify for its competitive advantage?

Medisolv's approval as a CMS Qualified Clinical Data Registry (QCDR) for 2026 signifies a strong competitive advantage in regulatory excellence and comprehensive data management. This designation enables Medisolv to offer robust, officially recognized reporting capabilities, distinguishing it from general EHRs and positioning it as a trusted partner for compliance.

What does Medisolv's 47% revenue reinvestment into research and innovation suggest about its long-term strategy?

Medisolv's reinvestment of 47% of its revenue back into research and innovation suggests a long-term strategy focused on continuous product development and market leadership. This commitment indicates a proactive approach to enhancing its technology, data analytics, and advisory services to meet evolving healthcare quality demands.

How does Medisolv's emphasis on Advisory Services and the Advanced Quality Improvement (AQI) subscription service impact its value proposition?

Medisolv's emphasis on Advisory Services and the AQI subscription service extends its value proposition beyond mere software provision, offering strategic quality improvement and expert guidance. This positions Medisolv as a comprehensive partner committed to driving measurable results and helping clients achieve continuous improvement, rather than just compliance.

What does Medisolv's leadership in Maryland's digital quality reporting initiative imply for its potential role in other state-level programs?

Medisolv's leadership in Maryland's digital quality reporting initiative, partnering with CRISP to accept eCQM data, implies a strong capability and potential for similar roles in other state-level programs. This pioneering effort demonstrates Medisolv's expertise in facilitating state-wide digital quality reporting, which could be replicated across other regions.

How does Medisolv's competition with CloudMedx, a company emphasizing AI, influence Medisolv's potential future product development?

Medisolv's competition with CloudMedx, which integrates AI for workflow automation and population health, suggests Medisolv may need to further enhance its AI capabilities. While Medisolv acquired Health Elements AI, continued pressure from AI-driven competitors might push them to more deeply embed AI in analytics and automation to maintain a competitive edge.

Powered by ForesightIQ · Competitive intelligence from digital exhaust